Bli medlem
Bli medlem

Du är här

2018-12-19

Inhalation Sciences: Inhalation Sciences receives new Contract Research order from global corporation based in Europe

December 19, Stockholm, Sweden. The order, worth 0.25 MSEK, follows a
successful earlier collaboration. ISAB CEO Lena Heffler: "Customers
as large and innovative as this one returning to carry out more
projects shows clearly how outstanding our data is, and the control
and precision it delivers."

This order is the result of a successful, earlier research
collaboration that delivered important data to the customer's
development project. The Contract Research will be carried out using
PreciseInhale, ISAB's advanced R&D aerosol lab system.

Precision dosing: controlled aerosol, controlled outcomes

Uniquely, PreciseInhale generates aerosols in precise, controllable
doses, producing exceptionally accurate-and repeatable-data. The
precision dosing methodology gives inhalation scientists outstanding
control of their aerosols, delivering data that eliminates errors in
early-stage research, and significantly reduces the development time
and cost of development of new inhaled therapies.

För mer information om Inhalation Sciences, vänligen kontakta:

Lena Heffler, VD
Epost: lena.heffler@inhalation.se
Tel: +46 (0)70 205 96 20

Om Inhalations Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) utvecklar och kommersialiserar
världsledande instrument för forskning inom inhalation. Bolagets
patenterade labinstrument, PreciseInhale® erbjuder forskare
möjligheten att, med mycket hög precision, karakterisera hur
aerosoler och små partiklar vid inandning påverkar våra lungor och
därmed vår hälsa.

-----------------------------------------------------------
http://news.cision.com/se/inhalation-sciences/r/inhalation-sciences-rece...
https://mb.cision.com/Main/15842/2704015/965934.pdf

Författare Aktietorget

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.